Found 280 matching trials
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) PHASE3 This multi-center, randomized, double blind, parallel-group, placebo-contro...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder PHASE3 Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Show More Location
Multiple Locations
Learn More & Join Trial
InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics N/A International Observational Registry on Schizophrenia...
Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) PHASE2 To evaluate the efficacy and safety of adjunctive pimavanserin compared wit...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine PHASE1 This Phase 1b Study RDX-002-22-09 has been planned to evaluate the effect o...
Show More Learn More & Join Trial
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms PHASE2 To explore the efficacy of SPD489, as adjunctive therapy to a stable dose o...
Show More Location
K&S Professional Research Services
Learn More & Join Trial
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia PHASE3 The purpose of the study is to evaluate the safety, tolerability and treatm...
Show More Location
Multiple Locations
Learn More & Join Trial
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis PHASE4 SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Show More Location
Multiple Locations
Learn More & Join Trial
A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine PHASE1 Through self-controlled studies on metabolic syndrome related indicators, e...
Show More Location
Multiple Locations
Learn More & Join Trial
VA Augmentation and Switching Treatments for Improving Depression Outcomes PHASE3 The overall purpose is to determine research based 'next-steps' for outpati...
Show More Location
Tuscaloosa VA Medical Center, Tuscaloosa, AL
Learn More & Join Trial